Literature DB >> 214334

Potentiative effects of sulfhydryl compounds on carrageenin-induced oedema in rats and relationship to their potencies as inhibitors of angiostin-coverting enzyme in vivo.

T Iso, H Yamauchi, H Suda, N Nakajima, K Nishimura, J Iwao.   

Abstract

Carrageenin-induced oedema in rats was potentiated by oral administration of (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (SA291) and related sulfhydryl compounds, and the effect was closely correlated with their potencies as inhibitors of angiotensin-converting enzyme in vivo.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 214334     DOI： 10.1007/bf01922957

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  9 in total

Review 1.  The kinins. A status report.

Authors:  E G Erdös
Journal:  Biochem Pharmacol       Date:  1976-07-15       Impact factor: 5.858

2.  Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

Authors:  D W Cushman; H S Cheung; E F Sabo; M A Ondetti
Journal:  Biochemistry       Date:  1977-12-13       Impact factor: 3.162

3.  New sulfhydryl compounds with potent antihypertensive activities.

Authors:  I Mita; J Iwao; M Oya; T Chiba; T Iso
Journal:  Chem Pharm Bull (Tokyo)       Date:  1978-04       Impact factor: 1.645

4.  Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

Authors:  M Di Rosa; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

5.  Proceedings: the concomitant release of bradykinin and prostaglandin in the inflammatory response to carrageenin.

Authors:  S H Ferreira; S Moncada; M Parsons; J R Vane
Journal:  Br J Pharmacol       Date:  1974-09       Impact factor: 8.739

6.  Enhancement of carrageenin foot oedema by 1,10 -phenanthroline and evidence for the bradykinin as endogenous mediator.

Authors:  F Capasso; B Balestrieri; M Di Rosa; P Persico; L Sorrentino
Journal:  Agents Actions       Date:  1975-10

7.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors:  M A Ondetti; B Rubin; D W Cushman
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

8.  Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme).

Authors:  H Y Yang; E G Erdös; Y Levin
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

9.  Inhibition by various substances of oedema formation in the bind-paw of the rat induced by 5-hydroxytryptamine, histamine, dextran, egg-white and compound 48/80.

Authors:  J R PARRATT; G B WEST
Journal:  Br J Pharmacol Chemother       Date:  1958-03
  9 in total
  3 in total

1.  Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and aminopeptidase P in rat paws.

Authors:  J Damas; J F Liégeois; W H Simmons
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Effect of angiotensin-converting enzyme inhibitor YS980 on prostaglandin synthesis in rabbit kidney medulla slices.

Authors:  Y Fujimoto; K Wada; M Kaneko; T Fujita
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

3.  Some pharmacological properties of tiopronin.

Authors:  F Capasso
Journal:  Agents Actions       Date:  1981-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.